Skip to main content
Top
Published in: Network Modeling Analysis in Health Informatics and Bioinformatics 1/2016

01-12-2016 | Original Article

A holistic approach for integration of biological systems and usage in drug discovery

Authors: Manish Kumar Gupta, Krishna Misra

Published in: Network Modeling Analysis in Health Informatics and Bioinformatics | Issue 1/2016

Log in

Activate our intelligent search to find suitable subject content or patents.

search-config
loading …

Abstract

A system can be defined as an organized, interconnected structure consisting of interrelated and interdependent elements (e.g., components, factors, members, parts). These parts and processes are connected by structural and/or behavioral relationships and continually influence one another directly or indirectly to maintain a balance essential for the existence of the system, and for achieving its goal. With increasing inflow of biological data, serious efforts to empathize biological systems as true systems are nowadays almost practicable. Handling high-throughput data places stress mainly on in silico approach comprising database handling, modeling, simulation and analysis, resulting in dramatic progress in system-level analysis. The databases and methods in bioinformatics are now moving in the direction of implementation of integrative dataset systems to represent genes, proteins and metabolic pathways in combination with simulated environment which is dynamic. For understanding the complex biological disorders and normal pathways of system it is significant to integrate the reductionist data which comes from transcriptomics, genomics, proteomics, lipidomics, glycomics, fluxomics and metabolomics. Numerous bioinformatics approaches are being exploited to integrate the molecular information from the biological databases and assist in simulation of metabolic networks. High-throughput experimental data set systems are, however, established on the static representation of the molecular data and existing knowledge. Various biological tools have been developed for understanding the mechanism of several diseases for drug discovery process. Study of dynamic nature of genetic, biochemical and signal transduction pathways can be done by simulating reactions with the help of integrative tools. Rising usage of rational drug designing approach is significant for identification of target in disease polluted network and evaluating ligand interaction for enhanced efficacy. How in-depth investigation of the whole system (a holistic approach) leads to emergence of systems biology is the crux of this review.

Dont have a licence yet? Then find out more about our products and how to get one now:

Springer Professional "Wirtschaft+Technik"

Online-Abonnement

Mit Springer Professional "Wirtschaft+Technik" erhalten Sie Zugriff auf:

  • über 102.000 Bücher
  • über 537 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Maschinenbau + Werkstoffe
  • Versicherung + Risiko

Jetzt Wissensvorsprung sichern!

Springer Professional "Technik"

Online-Abonnement

Mit Springer Professional "Technik" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 390 Zeitschriften

aus folgenden Fachgebieten:

  • Automobil + Motoren
  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Elektrotechnik + Elektronik
  • Energie + Nachhaltigkeit
  • Maschinenbau + Werkstoffe




 

Jetzt Wissensvorsprung sichern!

Springer Professional "Wirtschaft"

Online-Abonnement

Mit Springer Professional "Wirtschaft" erhalten Sie Zugriff auf:

  • über 67.000 Bücher
  • über 340 Zeitschriften

aus folgenden Fachgebieten:

  • Bauwesen + Immobilien
  • Business IT + Informatik
  • Finance + Banking
  • Management + Führung
  • Marketing + Vertrieb
  • Versicherung + Risiko




Jetzt Wissensvorsprung sichern!

Literature
go back to reference Aderem A, Adkins JN, Ansong C, Galagan J, Kaiser S, Korth MJ, Law GL, McDermott JG, Proll SC, Rosenberger C, Schoolnik G, Katze MG (2011) A systems biology approach to infectious disease research: innovating the pathogen-host research paradigm. MBio 2:e00325–e00410CrossRef Aderem A, Adkins JN, Ansong C, Galagan J, Kaiser S, Korth MJ, Law GL, McDermott JG, Proll SC, Rosenberger C, Schoolnik G, Katze MG (2011) A systems biology approach to infectious disease research: innovating the pathogen-host research paradigm. MBio 2:e00325–e00410CrossRef
go back to reference Arrell DK, Terzic A (2010) Network systems biology for drug discovery. Clin Pharmacol Ther 88:120–125CrossRef Arrell DK, Terzic A (2010) Network systems biology for drug discovery. Clin Pharmacol Ther 88:120–125CrossRef
go back to reference Atluri G, Padmanabhan K, Fang G, Steinbach M, Petrella JR, Lim K, Macdonald A 3rd, Samatova NF, Doraiswamy PM, Kumar V (2013) Complex biomarker discovery in neuroimaging data: finding a needle in a haystack. Neuroimage Clin 3:123–131CrossRef Atluri G, Padmanabhan K, Fang G, Steinbach M, Petrella JR, Lim K, Macdonald A 3rd, Samatova NF, Doraiswamy PM, Kumar V (2013) Complex biomarker discovery in neuroimaging data: finding a needle in a haystack. Neuroimage Clin 3:123–131CrossRef
go back to reference Atreya RV, Sun J, Zhao Z (2013) Exploring drug–target interaction networks of illicit drugs. BMC Genom 14(Suppl 4):S1CrossRef Atreya RV, Sun J, Zhao Z (2013) Exploring drug–target interaction networks of illicit drugs. BMC Genom 14(Suppl 4):S1CrossRef
go back to reference Bai JP, Abernethy DR (2013) Systems pharmacology to predict drug toxicity: integration across levels of biological organization. Annu Rev Pharmacol Toxicol 53:451–473CrossRef Bai JP, Abernethy DR (2013) Systems pharmacology to predict drug toxicity: integration across levels of biological organization. Annu Rev Pharmacol Toxicol 53:451–473CrossRef
go back to reference Barabási AL, Gulbahce N, Loscalzo J (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12:56–68CrossRef Barabási AL, Gulbahce N, Loscalzo J (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12:56–68CrossRef
go back to reference Bruggeman FJ, Westerhoff HV (2007) The nature of systems biology. Trends Microbiol 15:45–50CrossRef Bruggeman FJ, Westerhoff HV (2007) The nature of systems biology. Trends Microbiol 15:45–50CrossRef
go back to reference Bruggeman FJ, Hornberg JJ, Boogerd FC, Westerhoff HV (2007) Introduction to systems biology. EXS 97:1–19 Bruggeman FJ, Hornberg JJ, Boogerd FC, Westerhoff HV (2007) Introduction to systems biology. EXS 97:1–19
go back to reference Butcher EC, Berg EL, Kunkel EJ (2004) Systems biology in drug discovery. Nat Biotechnol 22:1253–1259CrossRef Butcher EC, Berg EL, Kunkel EJ (2004) Systems biology in drug discovery. Nat Biotechnol 22:1253–1259CrossRef
go back to reference Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, Sulman EP, Anne SL, Doetsch F, Colman H, Lasorella A, Aldape K, Califano A, Iavarone A (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463:318–325CrossRef Carro MS, Lim WK, Alvarez MJ, Bollo RJ, Zhao X, Snyder EY, Sulman EP, Anne SL, Doetsch F, Colman H, Lasorella A, Aldape K, Califano A, Iavarone A (2010) The transcriptional network for mesenchymal transformation of brain tumours. Nature 463:318–325CrossRef
go back to reference Chan SY, Loscalzo J (2012) The emerging paradigm of network medicine in the study of human disease. Circ Res 111:359–374CrossRef Chan SY, Loscalzo J (2012) The emerging paradigm of network medicine in the study of human disease. Circ Res 111:359–374CrossRef
go back to reference Charloteaux B, Zhong Q, Dreze M, Cusick ME, Hill DE, Vidal M (2011) Protein-protein interactions and networks: forward and reverse edgetics. Methods MolBiol 759:197–213 Charloteaux B, Zhong Q, Dreze M, Cusick ME, Hill DE, Vidal M (2011) Protein-protein interactions and networks: forward and reverse edgetics. Methods MolBiol 759:197–213
go back to reference Chen D, Zhang F, Tang S, Chen Y, Lu P, Wen S, Zhang H, Liu X, Chao E, Yang H (2013a) A network-based systematic study for the mechanism of the treatment of zhengs related to cough variant asthma. Evid Based Complement Alternat Med 2013:595924 Chen D, Zhang F, Tang S, Chen Y, Lu P, Wen S, Zhang H, Liu X, Chao E, Yang H (2013a) A network-based systematic study for the mechanism of the treatment of zhengs related to cough variant asthma. Evid Based Complement Alternat Med 2013:595924
go back to reference Chen L, Lu J, Zhang J, Feng K-R, Zheng M-Y, Cai Y-D (2013b) Predicting chemical toxicity effects based on chemical-chemical interactions. PLoS ONE 8:e56517CrossRef Chen L, Lu J, Zhang J, Feng K-R, Zheng M-Y, Cai Y-D (2013b) Predicting chemical toxicity effects based on chemical-chemical interactions. PLoS ONE 8:e56517CrossRef
go back to reference Clune J, Mouret JB, Lipson H (2013) The evolutionary origins of modularity. Proc Biol Sci 280:20122863CrossRef Clune J, Mouret JB, Lipson H (2013) The evolutionary origins of modularity. Proc Biol Sci 280:20122863CrossRef
go back to reference Colegrave N, Collins S (2008) Experimental evolution: experimental evolution and evolvability. Heredity Edinb 100:464–470CrossRef Colegrave N, Collins S (2008) Experimental evolution: experimental evolution and evolvability. Heredity Edinb 100:464–470CrossRef
go back to reference Creighton CJ (2012) Molecular classification and drug response prediction in cancer. Curr Drug Targets 13:1488–1494CrossRef Creighton CJ (2012) Molecular classification and drug response prediction in cancer. Curr Drug Targets 13:1488–1494CrossRef
go back to reference Csermely P, Korcsmáros T, Kiss HJ, London G, Nussinov R (2013) Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol Ther 138:333–408CrossRef Csermely P, Korcsmáros T, Kiss HJ, London G, Nussinov R (2013) Structure and dynamics of molecular networks: a novel paradigm of drug discovery: a comprehensive review. Pharmacol Ther 138:333–408CrossRef
go back to reference de Visser JA, Hermisson J, Wagner GP, Ancel Meyers L, Bagheri-Chaichian H, Blanchard JL, Chao L, Cheverud JM, Elena SF, Fontana W, Gibson G, Hansen TF, Krakauer D, Lewontin RC, Ofria C, Rice SH, von Dassow G, Wagner A, Whitlock MC (2003) Perspective: evolution and detection of genetic robustness. Evolution 57:1959–1972 de Visser JA, Hermisson J, Wagner GP, Ancel Meyers L, Bagheri-Chaichian H, Blanchard JL, Chao L, Cheverud JM, Elena SF, Fontana W, Gibson G, Hansen TF, Krakauer D, Lewontin RC, Ofria C, Rice SH, von Dassow G, Wagner A, Whitlock MC (2003) Perspective: evolution and detection of genetic robustness. Evolution 57:1959–1972
go back to reference Dent P (2014) Crosstalk between ERK, AKT, and cell survival. Cancer Biol Ther 15:245–246CrossRef Dent P (2014) Crosstalk between ERK, AKT, and cell survival. Cancer Biol Ther 15:245–246CrossRef
go back to reference Durmuş Tekir SD, Ülgen KÖ (2013) Systems biology of pathogen-host interaction: networks of protein-protein interaction within pathogens and pathogen-human interactions in the post-genomic era. Biotechnol J 8:85–96CrossRef Durmuş Tekir SD, Ülgen KÖ (2013) Systems biology of pathogen-host interaction: networks of protein-protein interaction within pathogens and pathogen-human interactions in the post-genomic era. Biotechnol J 8:85–96CrossRef
go back to reference Emig D, Ivliev A, Pustovalova O, Lancashire L, Bureeva S, Nikolsky Y, Bessarabova M (2013) Drug target prediction and repositioning using an integrated network-based approach. PLoS ONE 8:e60618CrossRef Emig D, Ivliev A, Pustovalova O, Lancashire L, Bureeva S, Nikolsky Y, Bessarabova M (2013) Drug target prediction and repositioning using an integrated network-based approach. PLoS ONE 8:e60618CrossRef
go back to reference Furlong LI (2013) Human diseases through the lens of network biology. Trends Genet 29:150–159CrossRef Furlong LI (2013) Human diseases through the lens of network biology. Trends Genet 29:150–159CrossRef
go back to reference Gottlieb A, Stein GY, Ruppin E, Sharan R (2011) PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol 7:496CrossRef Gottlieb A, Stein GY, Ruppin E, Sharan R (2011) PREDICT: a method for inferring novel drug indications with application to personalized medicine. Mol Syst Biol 7:496CrossRef
go back to reference Greene CS, Tan J, Ung M, Moore JH, Cheng C (2014) Big data bioinformatics. J Cell Physiol 229:1896–1900 Greene CS, Tan J, Ung M, Moore JH, Cheng C (2014) Big data bioinformatics. J Cell Physiol 229:1896–1900
go back to reference Gupta MK, Misra K (2013) Modeling and simulation analysis of propyl-thiouracil PTU, an anti-thyroid drug on thyroid peroxidase TPO, thyroid stimulating hormone receptor TSHR, and sodium iodide NIS symporter based on systems biology approach. Netw Model Anal Health Inform Bioinforma 2:45–57CrossRef Gupta MK, Misra K (2013) Modeling and simulation analysis of propyl-thiouracil PTU, an anti-thyroid drug on thyroid peroxidase TPO, thyroid stimulating hormone receptor TSHR, and sodium iodide NIS symporter based on systems biology approach. Netw Model Anal Health Inform Bioinforma 2:45–57CrossRef
go back to reference Gupta MK, Misra K (2014) Atom-based 3D-QSAR, molecular docking and molecular dynamics simulation assessment of inhibitors for thyroid hormone receptor α and β. J Mol Model 20:2286CrossRef Gupta MK, Misra K (2014) Atom-based 3D-QSAR, molecular docking and molecular dynamics simulation assessment of inhibitors for thyroid hormone receptor α and β. J Mol Model 20:2286CrossRef
go back to reference Gupta MK, Singh DB, Rath SK, Misra K (2012) Metabolic modeling and simulation analysis of thyroid disorder pathway. J Comput Sci Syst Biol 5:52–61CrossRef Gupta MK, Singh DB, Rath SK, Misra K (2012) Metabolic modeling and simulation analysis of thyroid disorder pathway. J Comput Sci Syst Biol 5:52–61CrossRef
go back to reference Gupta MK, Singh DB, Shukla R, Misra K (2013) A comprehensive metabolic modeling of thyroid pathway in relation to thyroid pathophysiology and therapeutics. OMICS: Journal of integrative biology 17:584-93 Gupta MK, Singh DB, Shukla R, Misra K (2013) A comprehensive metabolic modeling of thyroid pathway in relation to thyroid pathophysiology and therapeutics. OMICS: Journal of integrative biology 17:584-93
go back to reference Harris M, Bhuvaneshwar K, Natarajan T, Sheahan L, Wang D, Tadesse MG, Shoulson I, Filice R, Steadman K, Pishvaian MJ, Madhavan S, Deeken J (2014) Pharmacogenomic characterization of gemcitabine response–a framework for data integration to enable personalized medicine. Pharmacogenet Genomics 24:81–93CrossRef Harris M, Bhuvaneshwar K, Natarajan T, Sheahan L, Wang D, Tadesse MG, Shoulson I, Filice R, Steadman K, Pishvaian MJ, Madhavan S, Deeken J (2014) Pharmacogenomic characterization of gemcitabine response–a framework for data integration to enable personalized medicine. Pharmacogenet Genomics 24:81–93CrossRef
go back to reference Hartung T, van Vliet E, Jaworska J, Bonilla L, Skinner N, Thomas R (2012) Systems toxicology. ALTEX 29:119–128CrossRef Hartung T, van Vliet E, Jaworska J, Bonilla L, Skinner N, Thomas R (2012) Systems toxicology. ALTEX 29:119–128CrossRef
go back to reference Huang LC, Wu X, Chen JY (2011) Predicting adverse side effects of drugs. BMC Genom 12(Suppl 5):S11CrossRef Huang LC, Wu X, Chen JY (2011) Predicting adverse side effects of drugs. BMC Genom 12(Suppl 5):S11CrossRef
go back to reference Iadevaia S, Lu Y, Morales FC, Mills GB, Ram PT (2010) Identification of optimal drug combinations targeting cellular networks: integrating phospho-proteomics and computational network analysis. Cancer Res 70:6704–6714CrossRef Iadevaia S, Lu Y, Morales FC, Mills GB, Ram PT (2010) Identification of optimal drug combinations targeting cellular networks: integrating phospho-proteomics and computational network analysis. Cancer Res 70:6704–6714CrossRef
go back to reference Iskar M, Zeller G, Zhao XM, van Noort V, Bork P (2012) Drug discovery in the age of systems biology: the rise of computational approaches for data integration. Curr Opin Biotechnol 23:609–616CrossRef Iskar M, Zeller G, Zhao XM, van Noort V, Bork P (2012) Drug discovery in the age of systems biology: the rise of computational approaches for data integration. Curr Opin Biotechnol 23:609–616CrossRef
go back to reference Johnson R (2012) Long non-coding RNAs in Huntington’s disease neurodegeneration. Neurobiol Dis 46:245–254CrossRef Johnson R (2012) Long non-coding RNAs in Huntington’s disease neurodegeneration. Neurobiol Dis 46:245–254CrossRef
go back to reference Joyce AR, Palsson BØ (2006) The model organism as a system: integrating ‘omics’ data sets. Nat Rev Mol Cell Biol 7:198–210CrossRef Joyce AR, Palsson BØ (2006) The model organism as a system: integrating ‘omics’ data sets. Nat Rev Mol Cell Biol 7:198–210CrossRef
go back to reference Kaltenbach HM, Stelling J (2012) Modular analysis of biological networks. AdvExp Med Biol 736:3–17CrossRef Kaltenbach HM, Stelling J (2012) Modular analysis of biological networks. AdvExp Med Biol 736:3–17CrossRef
go back to reference Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, Hufeisen SJ, Jensen NH, Kuijer MB, Matos RC, Tran TB, Whaley R, Glennon RA, Hert J, Thomas KL, Edwards DD, Shoichet BK, Roth BL (2009) Predicting new molecular targets for known drugs. Nature 462:175–181CrossRef Keiser MJ, Setola V, Irwin JJ, Laggner C, Abbas AI, Hufeisen SJ, Jensen NH, Kuijer MB, Matos RC, Tran TB, Whaley R, Glennon RA, Hert J, Thomas KL, Edwards DD, Shoichet BK, Roth BL (2009) Predicting new molecular targets for known drugs. Nature 462:175–181CrossRef
go back to reference Kim S, Jin D, Lee H (2013) Predicting drug–target interactions using drug–drug interactions. PLoS ONE 8:e80129CrossRef Kim S, Jin D, Lee H (2013) Predicting drug–target interactions using drug–drug interactions. PLoS ONE 8:e80129CrossRef
go back to reference Kitano H (2007) Scientific challenges in systems biology. In: Choi S (ed) Introduction to systems biology. Human press, Totowa, New Jersey, pp 3–13 Kitano H (2007) Scientific challenges in systems biology. In: Choi S (ed) Introduction to systems biology. Human press, Totowa, New Jersey, pp 3–13
go back to reference Klinke DJ (2010) 2nd, Signal transduction networks in cancer: quantitative parameters influence network topology. Cancer Res 70:1773–1782CrossRef Klinke DJ (2010) 2nd, Signal transduction networks in cancer: quantitative parameters influence network topology. Cancer Res 70:1773–1782CrossRef
go back to reference Klipp E, Herwig R, Kowald A, Wierling C, Lehrach H (2005) Basic principles, chapter 1, systems biology in practice: concepts implementation and application. Wiley-VCH Verlag GmbH & Co, KGaA, WeinheimCrossRef Klipp E, Herwig R, Kowald A, Wierling C, Lehrach H (2005) Basic principles, chapter 1, systems biology in practice: concepts implementation and application. Wiley-VCH Verlag GmbH & Co, KGaA, WeinheimCrossRef
go back to reference Kuepfer L (2010) Towards whole-body systems physiology. Mol Syst Biol 6:409CrossRef Kuepfer L (2010) Towards whole-body systems physiology. Mol Syst Biol 6:409CrossRef
go back to reference Lage K, Hansen NT, Karlberg EO, Eklund AC, Roque FS, Donahoe PK, Szallasi Z, Jensen TS, Brunak S (2008) A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexes. Proc Natl Acad Sci USA 105:20870–20875CrossRef Lage K, Hansen NT, Karlberg EO, Eklund AC, Roque FS, Donahoe PK, Szallasi Z, Jensen TS, Brunak S (2008) A large-scale analysis of tissue-specific pathology and gene expression of human disease genes and complexes. Proc Natl Acad Sci USA 105:20870–20875CrossRef
go back to reference Leung EL, Cao ZW, Jiang ZH, Zhou H, Liu L (2013) Network-based drug discovery by integrating systems biology and computational technologies. Brief Bioinform 14:491–505CrossRef Leung EL, Cao ZW, Jiang ZH, Zhou H, Liu L (2013) Network-based drug discovery by integrating systems biology and computational technologies. Brief Bioinform 14:491–505CrossRef
go back to reference Li X, Xu X, Wang J, Yu H, Wang X, Yang H, Xu H, Tang S, Li Y, Yang L, Huang L, Wang Y, Yang S (2012) A system-level investigation into the mechanisms of Chinese Traditional Medicine: compound Danshen Formula for cardiovascular disease treatment. PLoS ONE 7:e43918CrossRef Li X, Xu X, Wang J, Yu H, Wang X, Yang H, Xu H, Tang S, Li Y, Yang L, Huang L, Wang Y, Yang S (2012) A system-level investigation into the mechanisms of Chinese Traditional Medicine: compound Danshen Formula for cardiovascular disease treatment. PLoS ONE 7:e43918CrossRef
go back to reference Li M, Zeng T, Liu R, Chen L (2013) Detecting tissue-specific early warning signals for complex diseases based on dynamical network biomarkers: study of type 2 diabetes by cross-tissue analysis. Brief Bioinform 15:229–243CrossRef Li M, Zeng T, Liu R, Chen L (2013) Detecting tissue-specific early warning signals for complex diseases based on dynamical network biomarkers: study of type 2 diabetes by cross-tissue analysis. Brief Bioinform 15:229–243CrossRef
go back to reference Liu B, Zhang J, Tan PY, Hsu D, Blom AM, Leong B, Sethi S, Ho B, Ding JL, Thiagarajan PS (2011) A computational and experimental study of the regulatory mechanisms of the complement system. PLoS Comput Biol 7:1001059CrossRef Liu B, Zhang J, Tan PY, Hsu D, Blom AM, Leong B, Sethi S, Ho B, Ding JL, Thiagarajan PS (2011) A computational and experimental study of the regulatory mechanisms of the complement system. PLoS Comput Biol 7:1001059CrossRef
go back to reference Liu MX, Chen X, Chen G, Cui QH, Yan GY (2014) A computational framework to infer human disease-associated long noncoding RNAs. PLoS ONE 9:e84408CrossRef Liu MX, Chen X, Chen G, Cui QH, Yan GY (2014) A computational framework to infer human disease-associated long noncoding RNAs. PLoS ONE 9:e84408CrossRef
go back to reference Macisaac KD, Wang IM, Menetski J, Roberts C (2013) Genomic and systems approaches to translational biomarker discovery in immunological diseases. Drug Discov Today 19:133–139CrossRef Macisaac KD, Wang IM, Menetski J, Roberts C (2013) Genomic and systems approaches to translational biomarker discovery in immunological diseases. Drug Discov Today 19:133–139CrossRef
go back to reference Merelli I, Pérez-Sánchez H, Gesing S, D’Agostino D (2014) Managing, analysing, and integrating big data in medical bioinformatics: open problems and future perspectives. Biomed Res Int 2014:134023 Merelli I, Pérez-Sánchez H, Gesing S, D’Agostino D (2014) Managing, analysing, and integrating big data in medical bioinformatics: open problems and future perspectives. Biomed Res Int 2014:134023
go back to reference Min Y, Jin X, Chen M, Pan Z, Ge Y, Chang J (2011) Pathway knockout and redundancy in metabolic networks. J Theor Biol 270:63–69MathSciNetCrossRef Min Y, Jin X, Chen M, Pan Z, Ge Y, Chang J (2011) Pathway knockout and redundancy in metabolic networks. J Theor Biol 270:63–69MathSciNetCrossRef
go back to reference Naylor S, Chen JY (2010) Unraveling human complexity and disease with systems biology and personalized medicine. Per Med 7:275–289CrossRef Naylor S, Chen JY (2010) Unraveling human complexity and disease with systems biology and personalized medicine. Per Med 7:275–289CrossRef
go back to reference Peng Q, Schork NJ (2014) Utility of network integrity methods in therapeutic target identification. Front Genet 5:12CrossRef Peng Q, Schork NJ (2014) Utility of network integrity methods in therapeutic target identification. Front Genet 5:12CrossRef
go back to reference Qureshi IA, Mattick JS, Mehler MF (2010) Long non-coding RNAs in nervous system function and disease. Brain Res 1338:20–35CrossRef Qureshi IA, Mattick JS, Mehler MF (2010) Long non-coding RNAs in nervous system function and disease. Brain Res 1338:20–35CrossRef
go back to reference Readhead B, Dudley J (2013) Translational bioinformatics approaches to drug development. Adv Wound CareNew Rochelle 2:470–489CrossRef Readhead B, Dudley J (2013) Translational bioinformatics approaches to drug development. Adv Wound CareNew Rochelle 2:470–489CrossRef
go back to reference Reddy AS, Zhang S (2013) Polypharmacology: drug discovery for the future. Expert Rev Clin Pharmacol 6:41–47CrossRef Reddy AS, Zhang S (2013) Polypharmacology: drug discovery for the future. Expert Rev Clin Pharmacol 6:41–47CrossRef
go back to reference Sahni N, Yi S, Zhong Q, Jailkhani N, Charloteaux B, Cusick ME, Vidal M (2013) Edgotype: a fundamental link between genotype and phenotype. Curr Opin Genet Dev 23:649–657CrossRef Sahni N, Yi S, Zhong Q, Jailkhani N, Charloteaux B, Cusick ME, Vidal M (2013) Edgotype: a fundamental link between genotype and phenotype. Curr Opin Genet Dev 23:649–657CrossRef
go back to reference Schadt EE, Friend SH, Shaywitz DA (2009) A network view of disease and compound screening. Nat Rev Drug Discovery 8:286–295CrossRef Schadt EE, Friend SH, Shaywitz DA (2009) A network view of disease and compound screening. Nat Rev Drug Discovery 8:286–295CrossRef
go back to reference Shah SH, Kraus WE, Newgard CB (2012) Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. Circulation 126:1110–1120CrossRef Shah SH, Kraus WE, Newgard CB (2012) Metabolomic profiling for the identification of novel biomarkers and mechanisms related to common cardiovascular diseases: form and function. Circulation 126:1110–1120CrossRef
go back to reference Shahzad K, Loor JJ (2012) Application of top-down and bottom-up systems approaches in ruminant physiology and metabolism. Curr Genomics 13:379–394CrossRef Shahzad K, Loor JJ (2012) Application of top-down and bottom-up systems approaches in ruminant physiology and metabolism. Curr Genomics 13:379–394CrossRef
go back to reference Shapira SD, Gat-Viks I, Shum BOV, Dricot A, de Grace MM, Wu L, Gupta PB, Hao T, Silver SJ, Root DE, Hill DE, Regev A, Hacohen N (2009) A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139:1255–1267CrossRef Shapira SD, Gat-Viks I, Shum BOV, Dricot A, de Grace MM, Wu L, Gupta PB, Hao T, Silver SJ, Root DE, Hill DE, Regev A, Hacohen N (2009) A physical and regulatory map of host-influenza interactions reveals pathways in H1N1 infection. Cell 139:1255–1267CrossRef
go back to reference Spiros A, Geerts H (2012) A quantitative way to estimate clinical off-target effects for human membrane brain targets in CNS research and development. J Exp Pharmacol 4:53–61 Spiros A, Geerts H (2012) A quantitative way to estimate clinical off-target effects for human membrane brain targets in CNS research and development. J Exp Pharmacol 4:53–61
go back to reference Sun H, Xia M, Austin CP, Huang R (2012) Paradigm shift in toxicity testing and modeling. AAPS J 14:473–480CrossRef Sun H, Xia M, Austin CP, Huang R (2012) Paradigm shift in toxicity testing and modeling. AAPS J 14:473–480CrossRef
go back to reference Villaverde AF, Banga JR (2013) Reverse engineering and identification in systems biology: strategies, perspectives and challenges. J R Soc Interface 11:20130505CrossRef Villaverde AF, Banga JR (2013) Reverse engineering and identification in systems biology: strategies, perspectives and challenges. J R Soc Interface 11:20130505CrossRef
go back to reference Wang X, Gulbahce N, Yu H (2011) Network-based methods for human disease gene prediction. Brief Funct Genomics 10:280–293CrossRef Wang X, Gulbahce N, Yu H (2011) Network-based methods for human disease gene prediction. Brief Funct Genomics 10:280–293CrossRef
go back to reference Wang XD, Huang JL, Yang L, Wei DQ, Qi YX, Jiang ZL (2014) Identification of human disease genes from interactome network using graphlet interaction. PLoS ONE 9:e86142CrossRef Wang XD, Huang JL, Yang L, Wei DQ, Qi YX, Jiang ZL (2014) Identification of human disease genes from interactome network using graphlet interaction. PLoS ONE 9:e86142CrossRef
go back to reference Wapinski O, Chang HY (2011) Long noncoding RNAs and human disease. Trends Cell Biol 21:354–361CrossRef Wapinski O, Chang HY (2011) Long noncoding RNAs and human disease. Trends Cell Biol 21:354–361CrossRef
go back to reference Whitacre JM (2012) Biological robustness: paradigms, mechanisms, and systems principles. Front Genet 3:67 Whitacre JM (2012) Biological robustness: paradigms, mechanisms, and systems principles. Front Genet 3:67
go back to reference Yang F, Xu J, Zeng J (2013) Drug–target interaction prediction by integrating chemical, genomic, functional and pharmacological data. Pac Symp Biocomput 2014:148–159 Yang F, Xu J, Zeng J (2013) Drug–target interaction prediction by integrating chemical, genomic, functional and pharmacological data. Pac Symp Biocomput 2014:148–159
go back to reference Yang X, Gao L, Guo X, Shi X, Wu H, Song F, Wang B (2014) A Network Based Method for Analysis of lncRNA-Disease Associations and Prediction of lncRNAs Implicated in Diseases. PLoS ONE 9:e87797CrossRef Yang X, Gao L, Guo X, Shi X, Wu H, Song F, Wang B (2014) A Network Based Method for Analysis of lncRNA-Disease Associations and Prediction of lncRNAs Implicated in Diseases. PLoS ONE 9:e87797CrossRef
go back to reference Yera ER, Cleves AE, Jain AN (2014) Prediction of off-target drug effects through data fusion. Pac Symp Biocomput 19:160–171 Yera ER, Cleves AE, Jain AN (2014) Prediction of off-target drug effects through data fusion. Pac Symp Biocomput 19:160–171
go back to reference Yildirim MA, Goh KI, Cusick ME, Barabási AL, Vidal M (2007) Drug–target network. Nat Biotechnol 25:1119–1126CrossRef Yildirim MA, Goh KI, Cusick ME, Barabási AL, Vidal M (2007) Drug–target network. Nat Biotechnol 25:1119–1126CrossRef
go back to reference Zhao S, Iyengar R (2012) Systems pharmacology: network analysis to identify multiscale mechanisms of drug action. Annu Rev Pharmacol Toxicol 52:505–521CrossRef Zhao S, Iyengar R (2012) Systems pharmacology: network analysis to identify multiscale mechanisms of drug action. Annu Rev Pharmacol Toxicol 52:505–521CrossRef
go back to reference Zhu J, Qin Y, Liu T, Wang J, Zheng X (2013) Prioritization of candidate disease genes by topological similarity between disease and protein diffusion profiles. BMC Bioinformatics 14(Suppl 5):S5 Zhu J, Qin Y, Liu T, Wang J, Zheng X (2013) Prioritization of candidate disease genes by topological similarity between disease and protein diffusion profiles. BMC Bioinformatics 14(Suppl 5):S5
go back to reference Zou J, Ji P, Zhao Y-L, Li LL, Wei YQ, Chen YZ, Yang SY (2012) Neighbor communities in drug combination networks characterize synergistic effect. Molecular Bio Systems 8:3185–3196 Zou J, Ji P, Zhao Y-L, Li LL, Wei YQ, Chen YZ, Yang SY (2012) Neighbor communities in drug combination networks characterize synergistic effect. Molecular Bio Systems 8:3185–3196
go back to reference Zou J, Zheng MW, Li G, Su ZG (2013) Advanced systems biology methods in drug discovery and translational biomedicine. Biomed Res Int 2013:742835 Zou J, Zheng MW, Li G, Su ZG (2013) Advanced systems biology methods in drug discovery and translational biomedicine. Biomed Res Int 2013:742835
Metadata
Title
A holistic approach for integration of biological systems and usage in drug discovery
Authors
Manish Kumar Gupta
Krishna Misra
Publication date
01-12-2016
Publisher
Springer Vienna
Published in
Network Modeling Analysis in Health Informatics and Bioinformatics / Issue 1/2016
Print ISSN: 2192-6662
Electronic ISSN: 2192-6670
DOI
https://doi.org/10.1007/s13721-015-0111-4

Other articles of this Issue 1/2016

Network Modeling Analysis in Health Informatics and Bioinformatics 1/2016 Go to the issue

Premium Partner